 Connection
Olga Taraschenko to Drug Resistant Epilepsy
This is a "connection" page, showing publications Olga Taraschenko has written about Drug Resistant Epilepsy.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
3.130 |
|
|
|
-
Snehal I, Pulluru Y, Schissel M, Matyi J, Garlinghouse M, Ghonim HT, Phatak V, Taraschenko O. Impact of ictal spread on preoperative memory and language functions and postoperative seizure outcomes in drug-resistant epilepsy. Epilepsy Behav. 2025 Oct; 171:110497.
Score: 0.763
-
Pavuluri S, Gumenyuk V, Koh S, Salehi A, Cathcart S, Taraschenko O. Child Neurology: Functional Evaluation of the Dominant Hemisphere Using Magnetoencephalography Prior to Hemispherectomy. Neurology. 2022 10 04; 99(14):614-617.
Score: 0.628
-
Meletti S, Hanin A, Giovannini G, Bedin R, Burani M, Taruffi L, Orlandi N, Urbano T, D'Achille F, Malerba M, Basha MM, Eschbach K, Foreman B, Farias-Moeller R, Gaspard N, Gerard EE, Gofton T, Gopaul MT, Haider HA, Hantus ST, Herman S, Kang P, Day GS, Kandula P, Steriade C, Struck AF, Taraschenko O, Wainwright M, Yoo JY, Zhou DJ, Lattanzi S, Navarro V, Hirsch LJ. Acute Brain Injury in New-Onset Refractory Status Epilepticus and Etiology-Defined Status Epilepticus. JAMA Neurol. 2026 Jun 01; 83(6):563-572.
Score: 0.205
-
Eliashiv D, Rao VR, Jobst BC, Szaflarski JP, Rolston JD, Kaye LC, Ganguly TM, Bullinger K, Dugan PC, Burdette DE, Peters AY, Sheikh A, Haas KF, Nair DR, Mnatsakanyan L, Quraishi IH, Bensalem-Owen MK, Doherty MJ, Razavi B, Fisher TL, Skidmore C, Modur PN, Constantino TM, Salanova V, Cole AJ, Taraschenko O, Rivera-Cruz A, Wheless JW, Tandon N, Balabanov A, Aboumatar S, Fried I, Drees C, Shin HW, Jaisani Z, MacIver SE, Patra SE, Chang EF, Willie JT, Gwinn R, Stoub T, Stern JM, Crabtree T, Seale CG, McFadden SC, Norman JF, Johnson L, Morrell MJ. Postapproval Study for Brain-Responsive Neurostimulation for Drug-Resistant Focal Epilepsy: Three-Year Efficacy and Interim Safety Results. Neurology. 2026 May 12; 106(9):e214875.
Score: 0.203
-
Hanin A, Marois C, Guillemaud M, Chavez M, Cosme L, Hayatou Z, Besnard A, Goudard G, Masson V, Cousyn L, Cheval M, Denis JA, Alkouri R, Lamari F, Bisulli F, Eschbach K, Farias-Moeller R, Gaspard N, Gerard EE, Giovannini G, Gofton T, Gopaul MT, Kellogg M, Meletti S, Muccioli L, Pasini E, Taraschenko O, Torcida N, Wainwright MS, Yoo JY, Wong N, Bonnefont-Rousselot D, Demeret S, Hirsch LJ, Navarro V. Exploring pathways leading to drug-resistant epilepsy for patients with cryptogenic new onset refractory status epilepticus. Epilepsia. 2026 May; 67(5):2326-2346.
Score: 0.201
-
Gruen MD, Gopaul MT, Jimenez AD, Batra A, Blank LJ, Damien C, Day GS, Eschbach K, Gerard EE, Gofton TE, Hantus ST, Jette N, Jongeling A, Kang P, Kazazian K, Kellogg M, Kim M, Madani B, Morales M, Punia V, Steriade C, Struck A, Taraschenko O, Torcida N, Wainwright MS, Yoo JY, Gaspard N, Wong N, Hirsch LJ, Hanin A. Quality of life over time after new onset refractory status epilepticus. Epilepsia. 2026 01; 67(1):328-340.
Score: 0.195
-
Menousek J, Mordeson J, Dennis E, White ML, Taraschenko O, Abosch A. Enhanced Detection of Epileptogenic Zone Using Prisma 3T MRI in Patients with MRI-negative Focal Epilepsy. World Neurosurg. 2025 07; 199:124102.
Score: 0.190
-
Guillemaud M, Chavez M, Kobeissy F, Vezzani A, Jimenez AD, Basha MM, Batra A, Demeret S, Eka O, Eschbach K, Foreman B, Gaspard N, Gerard EE, Gofton TE, Haider HA, Hantus ST, Howe CL, Jongeling A, Kalkach-Aparicio M, Kandula P, Kazazian K, Kim M, Lai YC, Marois C, Mellor A, Mohamed W, Morales M, Pimentel CM, Ramirez AM, Steriade C, Struck AF, Taraschenko O, Torcida Sedano N, Wainwright MS, Yoo JY, Wang KKW, Navarro V, Hirsch LJ, Hanin A. Identification of Distinct Biological Groups of Patients With Cryptogenic NORSE via Inflammatory Profiling. Neurol Neuroimmunol Neuroinflamm. 2025 Jul; 12(4):e200403.
Score: 0.190
-
Espino PH, Eschbach K, Blank LJ, Cervenka MC, Muscal E, Farias-Moeller R, Gilmore EJ, Gopaul MT, Haider HA, Hanin A, Hirsch LJ, Kellogg MA, Kluger G, Lee ST, Melendez-Zaidi AE, Navarro V, Oliger AC, Pasini E, Reuner G, Sharpe CM, Sheikh ZB, Steigleder L, Steriade C, Stredny CM, Strzelczyk A, Taraschenko O, van Baalen A, Vinette SA, Wickström R, Wong NW, Yoo J, Gofton TE. New onset refractory status epilepticus: Long-term outcomes beyond seizures. Epilepsia. 2025 Apr; 66(4):988-1005.
Score: 0.186
-
Hanin A, Cespedes J, Pulluru Y, Gopaul M, Aronica E, Decampo D, Helbig I, Howe CL, Huttner A, Koh S, Navarro V, Taraschenko O, Vezzani A, Wilson MR, Xian J, Gaspard N, Hirsch LJ. Review and standard operating procedures for collection of biospecimens and analysis of biomarkers in new onset refractory status epilepticus. Epilepsia. 2023 06; 64(6):1444-1457.
Score: 0.165
-
Arcot Jayagopal L, Samson KK, Taraschenko O. Driving with drug-resistant and controlled seizures from a patient's perspective: Assessment of attitudes and practices. Epilepsy Behav. 2018 04; 81:101-106.
Score: 0.115
-
Hanin A, Jimenez AD, Gopaul M, Asbell H, Aydemir S, Basha MM, Batra A, Damien C, Day GS, Eka O, Eschbach K, Fatima S, Fields MC, Foreman B, Gerard EE, Gofton TE, Haider HA, Hantus ST, Hocker S, Jongeling A, Kalkach Aparicio M, Kandula P, Kang P, Kazazian K, Kellogg MA, Kim M, Lee JW, Marcuse LV, McGraw CM, Mohamed W, Orozco J, Pimentel CM, Punia V, Ramirez AM, Steriade C, Struck AF, Taraschenko O, Treister AK, Wainwright MS, Yoo JY, Zafar S, Zhou DJ, Zutshi D, Gaspard N, Hirsch LJ. Trends in management of patients with new-onset refractory status epilepticus (NORSE) from 2016 to 2023: An interim analysis. Epilepsia. 2024 Aug; 65(8):e148-e155.
Score: 0.045
-
Jimenez AD, Gopaul M, Asbell H, Aydemir S, Basha MM, Batra A, Damien C, Day GS, Eka O, Eschbach K, Fatima S, Fields MC, Foreman B, Gerard EE, Gofton TE, Haider HA, Hantus ST, Hocker S, Jongeling A, Kalkach Aparicio M, Kandula P, Kang P, Kazazian K, Kellogg MA, Kim M, Lee JW, Marcuse LV, McGraw CM, Mohamed W, Orozco J, Pimentel C, Punia V, Ramirez AM, Steriade C, Struck AF, Taraschenko O, Treister AK, Yoo JY, Zafar S, Zhou DJ, Zutshi D, Gaspard N, Hirsch LJ, Hanin A. Comparative analysis of patients with new onset refractory status epilepticus preceded by fever (febrile infection-related epilepsy syndrome) versus without prior fever: An interim analysis. Epilepsia. 2024 Jun; 65(6):e87-e96.
Score: 0.044
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|